China Pharma Holdings (CPHI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,867 | -20,702 | -10,750 | -19,278 | -9,183 |
| Depreciation Amortization | 2,680 | 2,929 | 3,259 | 3,291 | 3,078 |
| Income taxes - deferred | N/A | N/A | 68 | 123 | 308 |
| Accounts receivable | -614 | -479 | 99 | 51 | -1,098 |
| Accounts payable and accrued liabilities | -229 | 715 | 422 | -1,625 | 1,193 |
| Other Working Capital | 30 | 1,110 | 1,267 | 1,009 | 3,644 |
| Other Operating Activity | 958 | 17,035 | 7,517 | 17,270 | 4,953 |
| Operating Cash Flow | $-42 | $608 | $1,882 | $841 | $2,896 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -867 | -136 | -51 | -137 | -193 |
| Investing Cash Flow | $-867 | $-136 | $-51 | $-137 | $-193 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,871 | 692 | N/A | N/A | N/A |
| Debt Repayment | -2,247 | -2,420 | -2,264 | -1,480 | -1,505 |
| Other Financing Activity | 0 | 0 | 287 | 0 | -4,516 |
| Financing Cash Flow | $624 | $-1,729 | $-1,977 | $-1,480 | $-6,021 |
| Exchange Rate Effect | 58 | -19 | -134 | 140 | -264 |
| Beginning Cash Position | 1,185 | 2,461 | 2,740 | 2,666 | 6,249 |
| End Cash Position | 958 | 1,185 | 2,461 | 2,030 | 2,666 |
| Net Cash Flow | $-227 | $-1,276 | $-280 | $-636 | $-3,583 |
| Free Cash Flow | |||||
| Operating Cash Flow | -42 | 608 | 1,882 | 841 | 2,896 |
| Capital Expenditure | -867 | -136 | -51 | -137 | -193 |
| Free Cash Flow | -910 | 472 | 1,831 | 705 | 2,702 |